Literature DB >> 35613358

Ferroptosis at the crossroads of tumor-host interactions, metastasis, and therapy response.

Yinan Yao1, Yuxin Shi1, Zizhe Gao1, Yutong Sun2, Fan Yao1,3, Li Ma4,5.   

Abstract

Ferroptosis is a form of regulated cell death characterized by the accumulation of lipid peroxides in an iron-dependent manner. Ferroptotic cell death is modulated by many metabolic pathways, such as pathways governing the metabolism of sugars, lipids, amino acids, and iron, as well as mitochondrial activity and redox homeostasis. Tumor metastasis and therapy resistance are the main obstacles to curing cancers. Because tumor cells usually exhibit higher iron dependence than normal cells, they may be more susceptible to ferroptosis despite being resistant to other forms of cell death. Moreover, recent evidence has suggested that ferroptosis is involved in tumor-host interactions, modulates the tumor microenvironment, and serves as an antimetastatic mechanism. Thus, inducing ferroptosis in tumor cells has the potential to improve cancer treatment. Here, we review ferroptosis-regulating mechanisms and the roles of ferroptosis in malignant progression, including the tumor-host interactions, metastasis, and cancer therapy response.

Entities:  

Keywords:  ferroptosis; metastasis; therapy response; tumor-host interactions

Mesh:

Substances:

Year:  2022        PMID: 35613358      PMCID: PMC9273267          DOI: 10.1152/ajpcell.00148.2022

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   5.282


  87 in total

1.  Ferroptosis: an iron-dependent form of nonapoptotic cell death.

Authors:  Scott J Dixon; Kathryn M Lemberg; Michael R Lamprecht; Rachid Skouta; Eleina M Zaitsev; Caroline E Gleason; Darpan N Patel; Andras J Bauer; Alexandra M Cantley; Wan Seok Yang; Barclay Morrison; Brent R Stockwell
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

2.  Regulation of ferroptotic cancer cell death by GPX4.

Authors:  Wan Seok Yang; Rohitha SriRamaratnam; Matthew E Welsch; Kenichi Shimada; Rachid Skouta; Vasanthi S Viswanathan; Jaime H Cheah; Paul A Clemons; Alykhan F Shamji; Clary B Clish; Lewis M Brown; Albert W Girotti; Virginia W Cornish; Stuart L Schreiber; Brent R Stockwell
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582

3.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

4.  CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation.

Authors:  Hua Yuan; Xuemei Li; Xiuying Zhang; Rui Kang; Daolin Tang
Journal:  Biochem Biophys Res Commun       Date:  2016-08-07       Impact factor: 3.575

5.  Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL.

Authors:  Anja Schmitt; Wendan Xu; Philip Bucher; Melanie Grimm; Martina Konantz; Heike Horn; Myroslav Zapukhlyak; Philipp Berning; Marc Brändle; Mohamed-Ali Jarboui; Caroline Schönfeld; Karsten Boldt; Andreas Rosenwald; German Ott; Michael Grau; Pavel Klener; Petra Vockova; Claudia Lengerke; Georg Lenz; Klaus Schulze-Osthoff; Stephan Hailfinger
Journal:  Blood       Date:  2021-09-09       Impact factor: 22.113

6.  Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death.

Authors:  Javier Garcia-Bermudez; Lou Baudrier; Erol Can Bayraktar; Yihui Shen; Konnor La; Rohiverth Guarecuco; Burcu Yucel; Danilo Fiore; Bernardo Tavora; Elizaveta Freinkman; Sze Ham Chan; Caroline Lewis; Wei Min; Giorgio Inghirami; David M Sabatini; Kıvanç Birsoy
Journal:  Nature       Date:  2019-02-13       Impact factor: 49.962

7.  Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.

Authors:  Iuliia Efimova; Elena Catanzaro; Louis Van der Meeren; Victoria D Turubanova; Hamida Hammad; Tatiana A Mishchenko; Maria V Vedunova; Carmela Fimognari; Claus Bachert; Frauke Coppieters; Steve Lefever; Andre G Skirtach; Olga Krysko; Dmitri V Krysko
Journal:  J Immunother Cancer       Date:  2020-11       Impact factor: 13.751

8.  NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis.

Authors:  Samantha W Alvarez; Vladislav O Sviderskiy; Erdem M Terzi; Thales Papagiannakopoulos; Andre L Moreira; Sylvia Adams; David M Sabatini; Kıvanç Birsoy; Richard Possemato
Journal:  Nature       Date:  2017-11-22       Impact factor: 69.504

9.  BAP1 links metabolic regulation of ferroptosis to tumour suppression.

Authors:  Yilei Zhang; Jiejun Shi; Xiaoguang Liu; Li Feng; Zihua Gong; Pranavi Koppula; Kapil Sirohi; Xu Li; Yongkun Wei; Hyemin Lee; Li Zhuang; Gang Chen; Zhen-Dong Xiao; Mien-Chie Hung; Junjie Chen; Peng Huang; Wei Li; Boyi Gan
Journal:  Nat Cell Biol       Date:  2018-09-10       Impact factor: 28.824

10.  Lymph protects metastasizing melanoma cells from ferroptosis.

Authors:  Jessalyn M Ubellacker; Alpaslan Tasdogan; Vijayashree Ramesh; Bo Shen; Evann C Mitchell; Misty S Martin-Sandoval; Zhimin Gu; Michael L McCormick; Alison B Durham; Douglas R Spitz; Zhiyu Zhao; Thomas P Mathews; Sean J Morrison
Journal:  Nature       Date:  2020-08-19       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.